Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0001179110-22-001393 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-17 | 2022-02-15 | HALO | LaBrosse Nicole | SVP, CFO | F - Tax | $34.43 | -433 | 9,045 | -5% | -$14.9K |
| D | 2022-02-17 | 2022-02-15 | HALO | LaBrosse Nicole | SVP, CFO | M - OptEx | $0.00 | +1,255 | 9,478 | +15% | $0 |
| D | 2022-02-17 | 2022-02-15 | HALO | LaBrosse Nicole | SVP, CFO | M - OptEx | $0.00 | -1,255 | 3,762 | -25% | $0 |
| DM | 2022-02-17 | 2022-02-16 | HALO | LaBrosse Nicole | SVP, CFO | A - Grant | $0.00 | +82.7K | 20.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-15 | F | D | 433 | $34.43 | 9,045 | D | — | — | (F1) The reported disposition of 433 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 2 | Common | Common Stock | 2022-02-15 | M | A | 1,255 | $0.00 | 9,478 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-02-15 | M | D | 1,255 | $0.00 | 3,762 | D | $0.00 · — to — | 1,255 Common Stock | (F2) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |
| 4 | Derivative | Option to Purchase Common Stock | 2022-02-16 | A | A | 62,315 | $0.00 | 62,315 | D | $34.36 · 2023-02-16 to 2032-02-16 | 62,315 Common Stock | (F3) This option vests one-fourth on such date and then 1/48th monthly thereafter. |
| 5 | Derivative | Restricted Stock Units | 2022-02-16 | A | A | 20,373 | $0.00 | 20,373 | D | $0.00 · 2023-02-16 to — | 20,373 Common Stock | (F4) This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary thereafter. |